Rituximab for the Treatment of Myasthenia Gravis: A 2021 Update
Posté : 08 sept. 2021 12:35
Lu sur https://pubmed.ncbi.nlm.nih.gov/34255447/
Rituximab for the Treatment of Myasthenia Gravis: A 2021 Update [Internet]
Calvin Young, Sarah C. McGillOttawa (ON): Canadian Agency for Drugs and Technologies in Health; 2021 Apr.CADTH Health Technology Review.
- PMID: 34255447
- Bookshelf ID: NBK571915
Bonne lecture